Literature DB >> 11716967

Dose and dose rate effects of whole-body proton-irradiation on lymphocyte blastogenesis and hematological variables: part II.

Michael J Pecaut1, Daila S Gridley, Anna L Smith, Gregory A Nelson.   

Abstract

The goal of part II of this study was to evaluate functional characteristics of leukocytes and circulating blood cell parameters after whole-body proton irradiation at varying doses and at low- and high-dose-rates (LDR and HDR, respectively). C57BL/6 mice (n=51) were irradiated and euthanized at 4 days post-exposure for assay. Significant radiation dose- (but not dose-rate-) dependent decreases were observed in splenocyte responses to T and B cell mitogens when compared to sham-irradiated controls (P<0.001). Spontaneous blastogenesis, also significantly dose-dependent, was increased in both blood and spleen (P<0.001). Red blood cell counts, hemoglobin concentration, and hematocrit were decreased in a dose-dependent manner (P<0.05), whereas thrombocyte numbers were only slightly affected. Comparison of proton- and gamma-irradiated groups (both receiving 3 Gy at HDR) showed a higher level of spontaneous blastogenesis in blood leukocytes and a lower splenocyte response to concanavalin A following proton irradiation (P<0.05). There were no dose rate effects. Collectively, the data demonstrate that the measurements in blood and spleen were largely dependent upon the total dose of proton radiation and that an 80-fold difference in the dose rate was not a significant factor. A difference, however, was found between protons and gamma-rays in the degree of change induced in some of the measurements.

Entities:  

Keywords:  NASA Discipline Radiation Health; Non-NASA Center

Mesh:

Substances:

Year:  2002        PMID: 11716967     DOI: 10.1016/s0165-2478(01)00307-8

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Effects of proton radiation dose, dose rate and dose fractionation on hematopoietic cells in mice.

Authors:  J H Ware; J Sanzari; S Avery; C Sayers; G Krigsfeld; M Nuth; X S Wan; A Rusek; A R Kennedy
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

2.  Beta androstenediol mitigates the damage of 1 GeV/n Fe ion particle radiation to the hematopoietic system.

Authors:  Roger Loria; Mathew Beckman; Daniel Contaifer; Francisco Tamariz; David Gibb; Laura Thompson; Peter Guida
Journal:  Cancer Biother Radiopharm       Date:  2011-07-26       Impact factor: 3.099

3.  Analysis of white blood cell counts in mice after gamma- or proton-radiation exposure.

Authors:  Casey J Maks; X Steven Wan; Jeffrey H Ware; Ana L Romero-Weaver; Jenine K Sanzari; Jolaine M Wilson; Steve Rightnar; Andrew J Wroe; Peter Koss; Daila S Gridley; James M Slater; Ann R Kennedy
Journal:  Radiat Res       Date:  2011-04-08       Impact factor: 2.841

4.  Protective effects of dietary antioxidants on proton total-body irradiation-mediated hematopoietic cell and animal survival.

Authors:  Chris O Wambi; Jenine K Sanzari; Carly M Sayers; Manunya Nuth; Zhaozong Zhou; James Davis; Niklas Finnberg; Joan S Lewis-Wambi; Jeffrey H Ware; Wafik S El-Deiry; Ann R Kennedy
Journal:  Radiat Res       Date:  2009-08       Impact factor: 2.841

5.  Patents for Toll-like receptor ligands as radiation countermeasures for acute radiation syndrome.

Authors:  Vijay K Singh; Harvey B Pollard
Journal:  Expert Opin Ther Pat       Date:  2015-07-01       Impact factor: 6.674

6.  Leukocyte activity is altered in a ground based murine model of microgravity and proton radiation exposure.

Authors:  Jenine K Sanzari; Ana L Romero-Weaver; Gabrielle James; Gabriel Krigsfeld; Liyong Lin; Eric S Diffenderfer; Ann R Kennedy
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

Review 7.  Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization.

Authors:  Franco Cortese; Dmitry Klokov; Andreyan Osipov; Jakub Stefaniak; Alexey Moskalev; Jane Schastnaya; Charles Cantor; Alexander Aliper; Polina Mamoshina; Igor Ushakov; Alex Sapetsky; Quentin Vanhaelen; Irina Alchinova; Mikhail Karganov; Olga Kovalchuk; Ruth Wilkins; Andrey Shtemberg; Marjan Moreels; Sarah Baatout; Evgeny Izumchenko; João Pedro de Magalhães; Artem V Artemov; Sylvain V Costes; Afshin Beheshti; Xiao Wen Mao; Michael J Pecaut; Dmitry Kaminskiy; Ivan V Ozerov; Morten Scheibye-Knudsen; Alex Zhavoronkov
Journal:  Oncotarget       Date:  2018-02-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.